Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic

BACKGROUND: Allergen immunotherapy (AIT) must be continued for 3 years, to achieve a long-term modifying effect. Adherence is a key to ensure effectiveness. The objective of this study was, first of all, to evaluate the adherence with subcutaneous immunotherapy (SCIT) and to identify the main causes...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:World Allergy Organ J
Main Authors: Koca Kalkan, Ilkay, Ates, Hale, Aksu, Kurtulus, Yesilkaya, Selma, Topel, Musa, Cuhadar Ercelebi, Dilek, Turkyilmaz, Suleyman, Oncul, Ali, Demir, Senay
Formato: Artigo
Idioma:Inglês
Publicado: World Allergy Organization 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8185179/
https://ncbi.nlm.nih.gov/pubmed/34122718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.waojou.2021.100558
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares